Fisetin and luteolin protect human retinal pigment epithelial cells from oxidative stress-induced cell death and regulate inflammation

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Hytti, Maria ^a   Piippo, Niina ^a   Korhonen, Eveliina ^a   Honkakoski, Paavo ^a   Kaarniranta, Kai ^a,b   Kauppinen, Anu ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

FISETIN; FLAVONOID; LUTEOLIN;

CELL DEATH; CELL LINE; DRUG EFFECTS; EPITHELIUM CELL; HUMAN; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; RETINAL PIGMENT EPITHELIUM; SIGNAL TRANSDUCTION;

CELL DEATH; CELL LINE; EPITHELIAL CELLS; FLAVONOIDS; HUMANS; LUTEOLIN; MAP KINASE SIGNALING SYSTEM; OXIDATIVE STRESS; RETINAL PIGMENT EPITHELIUM;

EID: 84949257810     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17645     Document Type: Article

References (60)

1. Chung, H. Y. et al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res. Rev. 8, 18-30 (2009).
2. Kim, H. J. et al. Modulation of redox-sensitive transcription factors by calorie restriction during aging. Mech. Ageing Dev. 123, 1589-1595 (2002).
3. Xia, F. et al. Luteolin protects HUVECs from TNF-alpha-induced oxidative stress and inflammation via its effects on the Nox4/ROS-NF-kappaB and MAPK pathways. J. Atheroscler. Thromb. 21, 768-783 (2014).
4. Palanisamy, V., Jakymiw, A., Van Tubergen, E. A., D'Silva, N. J., Kirkwood, K. L. Control of cytokine mRNA expression by RNA-binding proteins and microRNAs. J. Dent. Res. 91, 651-658 (2012).
5. Bezzeri, V. et al. Mapping the transcriptional machinery of the IL-8 gene in human bronchial epithelial cells. J. Immunol. 187, 6069-6081 (2011).
6. Klettner, A. Oxidative stress induced cellular signaling in RPE cells. Front. Biosci. (Schol Ed) 4, 392-411 (2012).
7. Du, H. et al. JNK inhibition reduces apoptosis and neovascularization in a murine model of age-related macular degeneration. Proc. Natl. Acad. Sci. USA 110, 2377-2382 (2013).
8. Roduit, R., Schorderet, D. F. MAP kinase pathways in UV-induced apoptosis of retinal pigment epithelium ARPE19 cells. Apoptosis 13, 343-353 (2008).
9. Glotin, A. L. et al. Sustained versus transient ERK1/2 signaling underlies the anti-and proapoptotic effects of oxidative stress in human RPE cells. Invest. Ophthalmol. Vis. Sci. 47, 4614-4623 (2006).
10. King, R. E., Kent, K. D., Bomser, J. A. Resveratrol reduces oxidation and proliferation of human retinal pigment epithelial cells via extracellular signal-regulated kinase inhibition. Chem. Biol. Interact. 151, 143-149 (2005).
11. Funakoshi-Tago, M., Nakamura, K., Tago, K., Mashino, T., Kasahara, T. Anti-inflammatory activity of structurally related flavonoids, Apigenin, Luteolin and Fisetin. Int. Immunopharmacol. 11, 1150-1159 (2011).
12. Qiao, H. et al. Luteolin downregulates TLR4, TLR5, NF-kappaB and p-p38MAPK expression, upregulates the p-ERK expression, and protects rat brains against focal ischemia. Brain Res. 1448, 71-81 (2012).
13. Kalt, W., Hanneken, A., Milbury, P., Tremblay, F. Recent research on polyphenolics in vision and eye health. J. Agric. Food Chem. 58, 4001-4007 (2010).
14. Kapphahn, R. J. et al. Retinal proteins modified by 4-hydroxynonenal: identification of molecular targets. Exp. Eye Res. 83, 165-175 (2006).
15. Klettner, A. et al. Cellular and molecular mechanisms of age-related macular degeneration: from impaired autophagy to neovascularization. Int. J. Biochem. Cell Biol. 45, 1457-1467 (2013).
16. Klettner, A., Roider, J. Constitutive and oxidative-stress-induced expression of VEGF in the RPE are differently regulated by different Mitogen-activated protein kinases. Graefes Arch. Clin. Exp. Ophthalmol. 247, 1487-1492 (2009).
17. Sharma, A. et al. 4-Hydroxynonenal induces p53-mediated apoptosis in retinal pigment epithelial cells. Arch. Biochem. Biophys. 480, 85-94 (2008).
18. Pal, H. C. et al. Fisetin inhibits human melanoma cell invasion through promotion of mesenchymal to epithelial transition and by targeting MAPK and NFkappaB signaling pathways. PLoS One 9, e86338 (2014).
19. Wu, X. et al. ERK/PP1a/PLB/SERCA2a and JNK pathways are involved in luteolin-mediated protection of rat hearts and cardiomyocytes following ischemia/reperfusion. PLoS One 8, e82957 (2013).
20. Leotoing, L. et al. The polyphenol fisetin protects bone by repressing NF-kappaB and MKP-1-dependent signaling pathways in osteoclasts. PLoS One 8, e68388 (2013).
21. Chou, R. H. et al. Fisetin inhibits migration and invasion of human cervical cancer cells by down-regulating urokinase plasminogen activator expression through suppressing the p38 MAPK-dependent NF-kappaB signaling pathway. PLoS One 8, e71983 (2013).
22. Chien, C. S., Shen, K. H., Huang, J. S., Ko, S. C., Shih, Y. W. Antimetastatic potential of fisetin involves inactivation of the PI3K/Akt and JNK signaling pathways with downregulation of MMP-2/9 expressions in prostate cancer PC-3 cells. Mol. Cell. Biochem. 333, 169-180 (2010).
23. Kuo, M. Y. et al. Luteolin attenuates the pulmonary inflammatory response involves abilities of antioxidation and inhibition of MAPK and NFkappaB pathways in mice with endotoxin-induced acute lung injury. Food Chem. Toxicol. 49, 2660-2666 (2011).
24. Zhou, F. et al. Luteolin protects against reactive oxygen species-mediated cell death induced by zinc toxicity via the PI3K-Akt-NF-kappaB-ERK-dependent pathway. J. Neurosci. Res. 89, 1859-1868 (2011).
25. Park, C. M., Jin, K. S., Lee, Y. W., Song, Y. S. Luteolin and chicoric acid synergistically inhibited inflammatory responses via inactivation of PI3K-Akt pathway and impairment of NF-kappaB translocation in LPS stimulated RAW 264.7 cells. Eur. J. Pharmacol. 660, 454-459 (2011).
26. Kao, T. K. et al. Luteolin inhibits cytokine expression in endotoxin/cytokine-stimulated microglia. J. Nutr. Biochem. 22, 612-624 (2011).
27. Kim, S. C. et al. Inhibition of c-Jun N-terminal kinase and nuclear factor kappa B pathways mediates fisetin-exerted antiinflammatory activity in lipopolysccharide-treated RAW264.7 cells. Immunopharmacol. Immunotoxicol. 34, 645-650 (2012).
28. Park, H. H. et al. Anti-inflammatory activity of fisetin in human mast cells (HMC-1). Pharmacol. Res. 55, 31-37 (2007).
29. de Sousa, R. R. et al. Phosphoprotein levels, MAPK activities and NFkappaB expression are affected by fisetin. J. Enzyme Inhib. Med. Chem. 22, 439-444 (2007).
30. Ruiz, P. A., Haller, D. Functional diversity of flavonoids in the inhibition of the proinflammatory NF-kappaB, IRF, and Akt signaling pathways in murine intestinal epithelial cells. J. Nutr. 136, 664-671 (2006).
31. Kang, O. H., Choi, J. G., Lee, J. H., Kwon, D. Y. Luteolin isolated from the flowers of Lonicera japonica suppresses inflammatory mediator release by blocking NF-kappaB and MAPKs activation pathways in HMC-1 cells. Molecules 15, 385-398 (2010).
32. Xagorari, A., Roussos, C., Papapetropoulos, A. Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin. Br. J. Pharmacol. 136, 1058-1064 (2002).
33. Wu, W. et al. Luteolin inhibits inflammatory responses via p38/MK2/TTP-mediated mRNA stability. Molecules 18, 8083-8094 (2013).
34. Wolfle, U. et al. UVB-induced DNA damage, generation of reactive oxygen species, and inflammation are effectively attenuated by the flavonoid luteolin in vitro and in vivo. Free Radic. Biol. Med. 50, 1081-1093 (2011).
35. Chen, R. et al. Effects of the vegetable polyphenols epigallocatechin-3-gallate, luteolin, apigenin, myricetin, quercetin, and cyanidin in primary cultures of human retinal pigment epithelial cells. Mol. Vis. 20, 242-258 (2014).
36. Ando, C. et al. Luteolin, a food-derived flavonoid, suppresses adipocyte-dependent activation of macrophages by inhibiting JNK activation. FEBS Lett. 583, 3649-3654 (2009).
37. Jang, S., Kelley, K. W., Johnson, R. W. Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc. Natl. Acad. Sci. USA 105, 7534-7539 (2008).
38. Choi, E. Y., Jin, J. Y., Choi, J. I., Choi, I. S., Kim, S. J. Effects of luteolin on the release of nitric oxide and interleukin-6 by macrophages stimulated with lipopolysaccharide from Prevotella intermedia. J. Periodontol. 82, 1509-1517 (2011).
39. Kaarniranta, K. et al. Geldanamycin increases 4-hydroxynonenal (HNE)-induced cell death in human retinal pigment epithelial cells. Neurosci. Lett. 382, 185-190 (2005).
40. Paimela, T. et al. Celastrol regulates innate immunity response via NF-kappaB and Hsp70 in human retinal pigment epithelial cells. Pharmacol. Res. 64, 501-508 (2011).
41. Viiri, J. et al. Cis-urocanic acid suppresses UV-B-induced interleukin-6 and-8 secretion and cytotoxicity in human corneal and conjunctival epithelial cells in vitro. Mol. Vis. 15, 1799-1805 (2009).
42. Donmez, G., Guarente, L. Aging and disease: connections to sirtuins. Aging Cell. 9, 285-290 (2010).
43. Kauppinen, A., Suuronen, T., Ojala, J., Kaarniranta, K., Salminen, A. Antagonistic crosstalk between NF-kappaB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell. Signal. 25, 1939-1948 (2013).
44. Hubbard, B. P. et al. Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science 339, 1216-1219 (2013).
45. Hubbard, B. P., Sinclair, D. A. Small molecule SIRT1 activators for the treatment of aging and age-related diseases. Trends Pharmacol. Sci. 35, 146-154 (2014).
46. Bhattacharya, S., Chaum, E., Johnson, D. A., Johnson, L. R. Age-related susceptibility to apoptosis in human retinal pigment epithelial cells is triggered by disruption of p53-Mdm2 association. Invest. Ophthalmol. Vis. Sci. 53, 8350-8366 (2012).
47. Jun, E. J., Kim, H. S., Kim, Y. H. Role of HGF/c-Met in serum-starved ARPE-19 cells. Korean J. Ophthalmol. 21, 244-250 (2007).
48. Piippo, N. et al. Decline in cellular clearance systems induces inflammasome signaling in human ARPE-19 cells. Biochim. Biophys. Acta 1843, 3038-3046 (2014).
49. Hytti, M. et al. Quercetin alleviates 4-hydroxynonenal-induced cytotoxicity and inflammation in ARPE-19 cells. Exp. Eye Res. 132, 208-215 (2015).
50. Page, S. et al. 4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis. J. Biol. Chem. 274, 11611-11618 (1999).
51. Hanneken, A., Lin, F. F., Johnson, J., Maher, P. Flavonoids protect human retinal pigment epithelial cells from oxidative-stressinduced death. Invest. Ophthalmol. Vis. Sci. 47, 3164-3177 (2006).
52. Chen, C. Y., Peng, W. H., Tsai, K. D., Hsu, S. L. Luteolin suppresses inflammation-associated gene expression by blocking NFkappaB and AP-1 activation pathway in mouse alveolar macrophages. Life Sci. 81, 1602-1614 (2007).
53. Wang, Q. et al. Effect of berberine on proinflammatory cytokine production by ARPE-19 cells following stimulation with tumor necrosis factor-alpha. Invest. Ophthalmol. Vis. Sci. 53, 2395-2402 (2012).
54. Jin, T. et al. Fisetin up-regulates the expression of adiponectin in 3T3-L1 adipocytes via the activation of silent mating type information regulation 2 homologue 1 (SIRT1)-deacetylase and peroxisome proliferator-activated receptors (PPARs). J. Agric. Food Chem. 62, 10468-10474 (2014).
55. Rafacho, B. P. et al. Inhibition of diethylnitrosamine-initiated alcohol-promoted hepatic inflammation and precancerous lesions by flavonoid luteolin is associated with increased sirtuin 1 activity in mice. Hepatobiliary. Surg. Nutr. 4, 124-134 (2015).
56. Preyat, N., Leo, O. Sirtuin deacylases: a molecular link between metabolism and immunity. J. Leukoc. Biol. 93, 669-680 (2013).
57. Kubota, S. et al. Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation. Invest. Ophthalmol. Vis. Sci. 50, 3512-3519 (2009).
58. Nagai, N., Kubota, S., Tsubota, K., Ozawa, Y. Resveratrol prevents the development of choroidal neovascularization by modulating AMP-activated protein kinase in macrophages and other cell types. J. Nutr. Biochem. 25, 1218-1225 (2014).
59. Xie, J., Zhang, X., Zhang, L. Negative regulation of inflammation by SIRT1. Pharmacol. Res. 67, 60-67 (2013).
60. Sinclair, D. A., Guarente, L. Small-molecule allosteric activators of sirtuins. Annu. Rev. Pharmacol. Toxicol. 54, 363-380 (2014).